Sort   by:  
 Page size 
TranscriptomicsCharacterization of probiotic Escherichia coli isolates using a novel pangenome microarray
Background: Based on 32 Escherichia coli and Shigella genome sequences, we have developed an E. coli pan-genome microarray. Publicly available genomes were annotated in a consistent manor to define all currently known genes potentially present in the species. The chip design was evaluated by hybridi...
ORGANISM(S): Escherichia coli 
2010-05-26 | E-GEOD-8595 | biostudies-arrayexpress
UnknownCirculating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer.
Not available
S-EPMC7936069 | biostudies-literature
UnknownLong-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up.
Not available
S-EPMC8100571 | biostudies-literature
UnknownCyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
Not available
S-EPMC6506420 | biostudies-literature
UnknownThe Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial.
Not available
S-EPMC6368247 | biostudies-literature
UnknownTreatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.
Not available
S-EPMC6075846 | biostudies-literature
UnknownRetreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia.
Not available
S-EPMC12745032 | biostudies-literature
UnknownLong-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.
Not available
S-EPMC6449170 | biostudies-literature
UnknownOutcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Not available
S-EPMC5773840 | biostudies-literature
UnknownPalbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).
Not available
S-EPMC5061543 | biostudies-literature
Sort   by:  
 Page size